Article
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
1 Jan 2017
Abstract excerpt
BACKGROUND: MicroRNAs (miRNAs) have been shown to be involved in the initiation and progression of cancers in the literature. In this study, we aimed to evaluate the clinicopathological role of miR-17 in breast cancer. MATERIALS AND METHODS: The expression of miR-17 was measured in 132 breast cancer tissues and paired adjacent normal tissues by using real-time quantitative polymerase chain reaction. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
